$VLA (-35.27%) is working together with $PFE (-1.16%) on a vaccine for Lyme disease.
There is currently no vaccine for Lyme disease on the market, so the outcome of this investment could have been very high.
However, the story is not over yet. The vaccine is 70% effective.
If the regulatory authorities are cooperative, they may approve the vaccine for certain groups of people.
The much more realistic scenario is additional studies. Additional analyses and observational studies cost money and time. This means the vaccine would come on the market later.
$VLA (-35.27%) has other vaccines, but in the niche segment. A vaccine for Lyme disease could have contributed to major growth and that is exactly what I was speculating on.
I am also invested in the company myself. The first time was during the COVID pandemic. After that, I continued to follow the company and of course hoped for positive trial results.
Do any of you also have the share and would like to share your assessment? I look forward to every exchange in the comments.
